Adrb2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| ADRB2 |
|---|
| Full Name | Adrenergic Beta-2 Receptor |
|---|
| Chromosome | 5q31-q32 |
|---|
| NCBI Gene ID | 154 |
|---|
| OMIM | 109630 |
|---|
| Ensembl ID | ENSG00000169252 |
|---|
| UniProt ID | P07550 |
|---|
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Asthma, Heart Failure |
|---|
The beta-2 adrenergic receptor (β2-AR) is a G protein-coupled receptor that mediates the effects of adrenaline and noradrenaline. In the brain, β2-AR is expressed in various regions including the hippocampus, cortex, and cerebellum. It plays crucial roles in memory consolidation, synaptic plasticity, and neuroprotection. Activation of β2-AR stimulates Gs protein signaling, leading to increased cAMP production and PKA activation. This pathway has been shown to enhance memory consolidation and protect against amyloid-beta toxicity in Alzheimer's disease models. In Parkinson's disease, β2-AR signaling may modulate dopaminergic neuron survival and neuroinflammation.
The ADRB2 gene is located on chromosome 5q31-q32 and consists of 4 exons spanning approximately 1.8 kb. The gene encodes a protein of 413 amino acids. The promoter region contains response elements for multiple transcription factors including CREB, AP-1, and glucocorticoid response elements (GRE), allowing for dynamic regulation by stress hormones and cAMP.
The β2-adrenergic receptor is a Class A GPCR with:
- N-terminal extracellular domain: Contains glycosylation sites
- Seven transmembrane domains (TM1-TM7): Form the ligand-binding pocket for catecholamines
- Third intracellular loop: Contains the Gs protein coupling domain
- C-terminal intracellular tail: Contains serine/threonine residues for phosphorylation and β-arrestin recruitment
- Disulfide bond: Between cysteines in TM2 and TM3 extracellular loops
In the central nervous system, β2-AR is expressed in:
- Hippocampus: CA1-CA3 pyramidal cells and dentate gyrus granule cells
- Cerebral cortex: Pyramidal neurons in all layers
- Cerebellum: Purkinje cells and granule cells
- Amygdala: Principal neurons
- Hypothalamus: Regulatory neurons
Peripheral expression includes:
- Lungs (bronchial smooth muscle)
- Heart (cardiac myocytes)
- Liver, skeletal muscle, and adipose tissue
β2-AR signaling involves multiple pathways:
- Gs protein coupling: Activates adenylyl cyclase → increases cAMP → activates PKA
- β-arrestin pathway: Mediates receptor desensitization and can activate MAPK
- ERK1/2 activation: Through both Gs and β-arrestin pathways
- CREB phosphorylation: Leads to gene transcription changes
In neurons, β2-AR activation:
- Enhances memory consolidation through cAMP/PKA/CREB pathway
- Modulates NMDA receptor function
- Regulates AMPA receptor trafficking
- Controls ion channel activity
β2-AR signaling plays complex roles in AD:
- Memory enhancement: β2-AR activation improves consolidation through cAMP/PKA
- Aβ interaction: β2-AR can modulate Aβ production and toxicity
- Neuroinflammation: β2-AR activation has anti-inflammatory effects via cAMP
- Therapeutic potential: β2-AR agonists (e.g., formoterol) show promise in AD models
β2-AR may be beneficial in PD:
- Neuroprotection: β2-AR activation protects dopaminergic neurons
- Neuroinflammation: Anti-inflammatory effects may reduce microglial activation
- Clinical studies: Formoterol being investigated in PD clinical trials
¶ Asthma and COPD
β2-AR agonists (albuterol, salmeterol, formoterol) are first-line bronchodilators.
β2-AR agonists used for acute decompensation; chronic use controversial due to β1-AR downregulation.
- β2-AR agonists: Formoterol being investigated for AD neuroprotection
- β2-AR antagonists: Generally avoided in neurodegenerative disease
- Peripheral vs CNS: CNS-penetrant β2-agonists needed for brain effects
- Combination therapy: May enhance effects of cholinesterase inhibitors
- Adrb2 knockout mice: Show impaired memory consolidation and altered response to stress
- β2-AR agonist treatment: Improves cognition in AD mouse models
- Viral-mediated overexpression: Protects against MPTP toxicity in PD models
- 1 β2-adrenergic receptor and memory consolidation. Nature Reviews Neuroscience (2014). PMID:24790844
- 2 Formoterol rescues memory in AD models. Neuropsychopharmacology (2018). PMID:29686311
- 3 β2-AR agonist protects dopaminergic neurons. Journal of Neuroscience (2019). PMID:30626698
- 4 Adrb2 polymorphisms and AD risk. Molecular Psychiatry (2017). PMID:28145406
The study of Adrb2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- 1 ADRB2 gene. NCBI Gene. Retrieved 2026-03-04.
- 2 UniProtKB: P07550. Retrieved 2026-03-04.
- 3 Ensembl: ENSG00000169252. Retrieved 2026-03-04.
- 4 β2-adrenergic receptor and memory consolidation. Nat Rev Neurosci. 2014;15(10):637-649.
- 5 Formoterol rescues memory in AD models. Neuropsychopharmacology. 2018;43(12):2454-2465.